We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group.
- Authors
Cameron, D W; Heath-Chiozzi, M; Danner, S; Cohen, C; Kravcik, S; Maurath, C; Sun, E; Henry, D; Rode, R; Potthoff, A; Leonard, J
- Abstract
Ritonavir is a potent, orally bioavailable inhibitor of HIV-1 protease. We undertook an international, multicentre, randomised, double-blind, placebo-controlled trial of ritonavir in patients with HIV-1 infection and CD4-lymphocyte counts of 100 cells/microL or less, who had previously been treated with antiretroviral drugs.
- Publication
Lancet (London, England), 1998, Vol 351, Issue 9102, p543
- ISSN
0140-6736
- Publication type
Journal Article
- DOI
10.1016/s0140-6736(97)04161-5